Franck Bourdeaut

Franck Bourdeaut

Auto-generated profile, based on publicly available information

Franck Bourdeaut

Institut Curie, Paris, France

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2019 in Cancer Cell
Verified
Journal Article
Closed access
ALAmaury Leruste
Amaury Leruste
JTJimena Tosello
Jimena Tosello
RRRodrigo Nalio Ramos
Rodrigo Nalio Ramos
ATArnault Tauziède-Espariat
Arnault Tauziède-Espariat
SBSolène Brohard
Solène Brohard
FBFranck Bourdeaut
Franck Bourdeaut

1 February 2021 in The Lancet Child & Adolescent Health
Verified
Journal Article
Closed access
CKChristian P Kratz
Christian P Kratz
MJMarjolijn C Jongmans
Marjolijn C Jongmans
HCHélène Cavé
Hélène Cavé
KWKatharina Wimmer
Katharina Wimmer
SBSam Behjati
Sam Behjati
FBFranck Bourdeaut
Franck Bourdeaut

28 January 2016 in Nature Communications
Verified
Journal Article
Open access
ZHZhi-Yan Han
Zhi-Yan Han
WRWilfrid Richer
Wilfrid Richer
PFPaul Fréneaux
Paul Fréneaux
CCCéline Chauvin
Céline Chauvin
Carlo LUCCHESICarlo LUCCHESI
Carlo LUCCHESI
FBFranck Bourdeaut
Franck Bourdeaut
Rhabdoid tumours (RTs) are highly aggressive tumours of infancy, frequently localized in the central nervous system (CNS) where they are termed atypical teratoid/rhabdoid tumours (AT/RTs) and characterized by bi-allelic inactivation of the SMARCB1 tumour suppressor gene. In this study, by temporal control of tamoxifen injection in Smarcb1flox/flox;Rosa26-CreERT2 mice, we explore the phenotypes associated with Smarcb1 inactivation at different developmental stages. Injection before E6, at birth or at 2 months of age recapitulates previously described phenotypes including embryonic lethality, hepatic toxicity or development of T-cell lymphomas, respectively. Injection between E6 and E10 leads to high penetrance tumours, mainly intra-cranial, with short delays (median: 3 months). These tumours demonstrate anatomical, morphological and gene expression profiles consistent with those of human AT/RTs. Moreover, intra- and inter-species comparisons of tumours reveal that human and mouse RTs can be split into different entities that may underline the variety of RT cells of origin.

1 October 2015 in Gastroenterology
Verified
Journal Article
Closed access
SBSahra Bodo
Sahra Bodo
CCChrystelle Colas
Chrystelle Colas
OBOlivier Buhard
Olivier Buhard
ACAda Collura
Ada Collura
JTJulie Tinat
Julie Tinat
ADAlex Duval
Alex Duval

1 October 2005 in Cancer Letters
Verified
Journal Article
Closed access
FBFranck Bourdeaut
Franck Bourdeaut
DTDelphine Trochet
Delphine Trochet
IJIsabelle Janoueix-Lerosey
Isabelle Janoueix-Lerosey
ARAgnès Ribeiro
Agnès Ribeiro
ADAnne Deville
Anne Deville
ODOlivier Delattre
Olivier Delattre

27 May 2008 in Pediatric Blood & Cancer
Verified
Journal Article
Closed access
PDF file
FBFranck Bourdeaut
Franck Bourdeaut
PFPaul Fréneaux
Paul Fréneaux
BTBénédicte Thuille
Bénédicte Thuille
CBChristophe Bergeron
Christophe Bergeron
VLValérie Laurence
Valérie Laurence
DODaniel Orbach
Daniel Orbach